For drugs approaching IRA eligibility, apply the published MFP discount ranges from first-tranche negotiations as a base case, with sensitivity analysis on the contagion effect across the commercial market
So, in March 2023, Madison started GLP-1 medication through Claya, a weight loss and wellness company
For the first time, traditional drug spending surpassed specialty drug spending Pharmacy spending is expected to rise The market for GLP-1s continues to grow and the medicalization of weight loss continues to risefurther straining tight health care budgets
doi:10.1001/jamanetworkopen.2022.31982 Bray GA, Ryan DH
Tirzepatide has been shown to lower body weight and fat mass by decreasing food intake through appetite regulation and modulation of fat utilisation, with an associated improvement in health-related quality of life [17,18,19]